What is Recombinant Insulin, also known as Insulin Human AF, and how does it differ from animal-derived insulin? Recombinant Insulin consists of human insulin crystals – a biosynthetic product produced by recombinant microbial expression in yeast.
The yeast organism used to produce our recombinant insulin does not contain genes or express antigens of livestock or poultry disease agents. It is neither stored nor grown in media containing animal raw material. This means that our Recombinant Insulin supports major growth media suppliers’ definition of an animal-free product.
Our Recombinant Insulin is considered to be virologically safe, with a negligible risk of transferring BSE agents to the media or reagents in which our insulin is a component. With our Recombinant Insulin, you also avoid the risk of impurities such as mycoplasmas, which can pass line to line from the upstream bioreactor and contaminate your whole line.
Recombinant Insulin is a key component in serum-free growth media for mammalian cells. Ideal for manufacturing monoclonal antibodies, virus vaccines, gene therapy products, and other biological drug products, it stimulates the proliferation of cells and enhances the yield.
Learn more about our Recombinant Insulin here.
